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Abstract: Frangula emodin, (1,3,8-trihydroxy-6-methyl-anthraquinone), is one of the anthraquinone derivatives 
found abundantly in the roots and bark of a number of plant families traditionally used to treat constipation and 
haemorrhoids. The present study describes the development and subsequent validation of a specific assay HPLC 
method for emodin. The separation was achieved on a Waters Symmetry C18, 4.6 × 250 mm, 5 µm particle size, 
column at a temperature of 35 °C, with UV detection at 287 and 436 nm. An isocratic elution mode consisting of 
0.1% formic acid and 0.01% trifluoroacetic acid as the aqueous mobile phase, and methanol was used. The 
method was successfully and statistically validated for linearity, range, precision, accuracy, specificity and 
solution stability. 
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Introduction   
 
       A significant number of herbal medicinal 
products, despite their long tradition, do not fulfill 
the requirements imposed by European Union (EU) 
Directive 2004/24/EC on Traditional Herbal 
Medicinal Products, introduced in 20051, which 
states that companies manufacturing herbal 
medicinal drugs must show proof of the drug’s 
efficacy and pharmaceutical quality. To maintain 
these products on the market, companies must supply 
scientific evidence that proves the quality, safety and 
efficacy of their products. Frangula emodin, (1,3,8-
trihydroxy-6-methyl-anthraquinone) (Fig. 1), is one 
of the anthraquinone derivatives found abundantly in 
the roots and bark of Fabaceae (Cassia spp.), 
Polygonaceae (Rheum, Rumex and Polygonum spp.) 
and Rhamnaceae (Rhamnus and Ventilago spp.). 
These plants have been used traditionally in the 
Eastern world for their purgative effects to treat 
constipation and haemorrhoid 2, 3. The laxative 
properties have been attributed to the active 
constituents of these plants, one of which is emodin. 
 
Figure 1. Emodin structure 
 
Studies have shown emodin to display a number 
of biological activities such as anti-microbial4, 
immunosuppressive5, anti-diabetic6 and anti-
inflammatory activities7, 8. Moreover, emodin is 
thought to have anti-tumor properties. Studies have 
been performed both in vitro and in vivo, and results 
have shown emodin to have potential as a cytotoxic 
agent against a variety of human cancers including 
lung cancer9, liver cancer10, and gastric cancer11. 
Various methods have been reported in the 
literature for the analysis of emodin in a mixture of 
anthraquinones including thin layer 
chromatography12, high performance liquid 
chromatography (HPLC) with ultraviolet-visible 
(UV–Vis)13, photodiode array (PDA)14, 
fluorescence15 and mass spectrometric (MS)16 
detection. The disadvantage of running methods that 
were developed for the simultaneous determination 
of a number of anthraquinones is that in order to 
achieve sufficient separation between the peaks, they 
usually incorporate long run times.  For routine 
analysis of emodin, a simple and rapid analytical 
method is preferred.  Few reports of a specific 
validated UV spectrophotometric method for the 
assay quantification of Frangula emodin have been 
published to date17, 18. This study focused on 
supplying chromatographic information on the 
emodin molecule to meet the requirements imposed 
by the aforementioned directive, and enable further 
research and product development.   The first 
objective was to establish the physicochemical 
properties of emodin that were relevant to the 
development of a chromatographic method in terms 
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of sample preparation and HPLC analysis. Secondly, 
an assay HPLC method capable of identifying and 
quantifying emodin in the presence of related 
substances was developed and subsequently 
validated in accordance with the International 
Conference on Harmonisation (ICH) guideline 
Q2(R1) relating to the validation of analytical 
procedures19.  
 
Experimental Section  
 
Instrumentation 
A Waters Alliance 2695 Separations Module, 
consisting of an on-line degasser, quaternary pump, 
thermostatted sample compartment, auto-sampler, 
column heater/cooler and Waters 2998 PDA detector 
was employed. Data were acquired and processed 
using the Waters Empower 2.0 software.  A C18 
reversed phase column Waters Symmetry C18, 4.6 × 
250 mm, 5 µm particle size, was used for the 
separation. A Bruker AM250 Nuclear magnetic 
resonance (NMR) spectrophotometer fitted with 
1H and 13C probe of frequency 250.1 MHz for 1H and 
62.9 MHz for the 13C probe with the corresponding 
software Bruker Aspect 3000 pc using 16K for 1H 
NMR was used. 
 
Software 
ACD Chemsketch software version 10.00 
Calculator Plugins were used to predict pKa values 
and generate pKa plots, Marvin 6.1.6, 2014, 
ChemAxon (http://www.chemaxon.com). Statistical 
analysis was performed using Microsoft Excel and 
SPSS 20.0 for Windows. 
 
Chemicals and Reagents 
HPLC gradient grade methanol and 
trifluoroacetic acid (TFA) (> 99.0% purity) were 
purchased from Sigma Aldrich. Formic acid (98% 
purity) was obtained from Fischer Scientific (UK.). 
Deionized water was purified using the ELGA Pure 
Lab Classic System with 0.2 µm filter, TOC 1 to 3 
ppb and resistivity ≥ 18.2 MΩ-cm. The emodin 
working standard utilized during this research 
project was obtained from Applichem, Germany with 
the item code A2056. It was certified as being of 
HPLC grade and extracted from Rhamnus frangula. 
This working standard was used as the sample 
throughout the project. The reference standard of 
emodin of item code E7881 was obtained from 
Sigma Aldrich. The standard was extracted from 
Frangula bark and its HPLC purity was stated as 
being 96.10%.  
 
Standard Solution 
Working and reference standard solutions of 
emodin were prepared by dissolving accurately 
weighed amounts of emodin standard in 100% 
methanol, followed by 15 minute sonication and  
 
 
topping up to the mark to give a final concentration 
of 0.5 mg/mL. A similar standard concentration was 
selected in multiple studies20, 21, 22. The solutions 
were stored at 4 °C. 
 
Method Scouting and Development 
Several HPLC methods have been developed and 
validated for the analysis of anthraquinones. These 
methods primarily differ in the type of column used, 
mobile phase, flow rate and their applications. A 
literature survey was first performed in search of 
HPLC methods that included emodin as one of the 
analytes. Most methods were developed for the 
separation and determination of mixtures of 
anthraquinones present in various herbal extracts. 
Additionally they incorporated rather long runtimes 
to allow for the separation of the various 
components.  
 
Methods that included phosphate buffers23, 24 
were excluded as phosphate buffers are incompatible 
with certain detectors, including mass spectrometry. 
Hence in order to allow the rapid transfer of methods 
from UV detection to MS detection, the 
chromatographic parameters were chosen to be both 
UV and MS compatible. Preliminary testing was 
performed to establish the pKa of the emodin 
molecule and also to identify the UV wavelengths at 
which the emodin molecule absorbed most intensely. 
 
The shortlisted methods (Systems 1, 2 and 3), 
which were selected based upon the results of the 
preliminary testing, were attempted on the Waters 
Alliance HPLC injecting only the emodin working 
standard. The resultant chromatograms were 
examined for sensitivity, efficiency and separation 
characteristics. The retention time, peak area, United 
States Pharmacopeia (USP) plate count and USP 
tailing were measured. The method that produced the 
best results for the emodin peak (System 3) was 
further optimized for column temperature, detection 
wavelength and mobile phase composition to obtain 
specificity of the emodin peak in the shortest run 
time possible (Systems 4, 5 and 6). A small quantity 
of TFA was incorporated into the mobile phase to 
sharpen peaks and as a result improve peak 
efficiency and resolution. In order to determine the 
optimal TFA concentration that was compatible with 
the emodin molecule without exceeding the pH limit 
recommended by the column, two concentrations of 
TFA were analyzed on the HPLC (Systems 7 and 8) 
and the resultant chromatograms were examined for 
efficiency of peaks.  Specificity and the optimal 
detection wavelength were determined by 
performing peak purity testing using the PDA 
detector. The optimized method was then validated 
in accordance to the International Conference of 
Harmonization (ICH) guideline Q2(R1)19. 
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Table 1. Summary of HPLC methods investigated during method scouting and development. 
System Mobile Phase 
Constituents 
(A:B) 
Isocratic/Gradient 
Profile 
Flow 
Rate 
(mL/min) 
Column 
Temp. 
(°C) 
UV  
λ  
(nm) 
Retentio
n Time 
(mins) 
Reference 
1 
 
Water : 
methanol 
Gradient 
0 mins: 55%A 
0 to 6 min: 55% A 
6 to 9 min: 25% A 
9 to 18min: 0% A 
18 to 25min: 0% A 
1.0 25 436 21.090 18 
2 0.1% (v/v) 
Formic acid : 
methanol 
Gradient 
0 mins: 28% A 
0 to 5 min:20% A 
5 to 10 min: 15% A 
10 to 14min: 10% A 
1.0 50 N/A 21.871 25 
3 0.1% (v/v) 
Formic acid : 
methanol 
Isocratic 
15% A : 85% B 
1.0 25 254 9.629 26 
4 0.1% (v/v) 
Formic Acid : 
methanol 
Gradient 
0 mins: 28% A 
0 to 10 min:28% A 
10 to 21 min: 15% A 
21 to 30 min: 10% A 
1.0 35 254 19.408 Optimization of 
System 2 
5 0.1% (v/v) 
Formic Acid : 
methanol 
Gradient 
0 mins: 55%A 
0 to 6 min: 55% A 
6 to 9 min: 25% A 
9 to 18min: 0% A 
18 to 25min: 0% A 
1.0 35 254 
436 
17.051 Optimization of 
Systems 1 and 2 
6 0.1% (v/v) 
Formic Acid : 
methanol 
Isocratic 
10% A : 90% B 
1.0 35 254 
436 
6.425 Optimization of 
System 3 
7 0.1% TFA : 
methanol 
Isocratic 
10% A : 90% B 
1.0 35 254 
436 
5.985 Investigating the 
effect of TFA 
8 0.01% TFA : 
methanol 
Isocratic 
10% A : 90% B 
1.0 35 254 
436 
5.891 Investigating the 
effect of TFA 
9 0.01% TFA 
0.1% formic 
acid : methanol 
Isocratic  
10% A : 90% B 
1.0 35 254 
436 
5.905 Chosen 
optimized 
chromatographic  
conditions 
 
Results and Discussion  
 
Preliminary study of the emodin molecule 
The pKa of emodin generated using ACD 
Chemsketch software version 10.00, was found to be 
6.39 with an error of 0.2. This value appears to be a 
combination of the dissociation constants pKa1 and 
pKa2 which were reported as being 5.70 and 7.94 
respectively27. From this information it was deduced 
that an acidic mobile phase was preferable with a pH 
lower than 4.70 in order to have the emodin in a 
single ionization form. Due to the molecule’s acidic 
functionality, the emodin would be in its unionized 
form at pH’s lower than 4.70 and moreover in a 
‘robust pH zone’ which is vital for reproducible 
retention times. 
 
The UV spectrum of the emodin working 
standard dissolved in methanol (Fig. 2) gave a 
preliminary idea of the wavelengths that showed the 
highest absorption for emodin which is an important 
factor to consider when deciding on the detection 
wavelength for the HPLC method. A spectrum of 
pure methanol was also included as a blank to ensure 
that no interferences from the diluent were present. 
The electronic absorption spectrum of emodin was 
measured in methanol at room temperature in the 
wavelength region 200 to 700 nm. Five prominent 
bands were identified with maxima at 221, 252, 265, 
288 and 435 nm.  The spectrum matched the 
spectrum reported by Marković et al.28. The broad 
band at 435 nm was reported to have a dominant 
charge transfer character in the same research study. 
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Figure 2. UV-VIS spectrum of the emodin working standard in methanol using the Shimadzu UV-Vis 
spectrophotometer 
 
Method Development and Optimisation 
The optimal chromatographic conditions for the 
HPLC assay method for emodin are listed in Table. 
2, Full and Expanded integrated chromatograms are 
displayed in Fig. 3 (A) and 3 (B). 
 
Table 2. HPLC method parameters for the assay determination of emodin (System 9). 
Column Waters Symmetry C18 250 x 4.6 mm, 5 µm 
 
Mobile Phase Mobile Phase A: 0.01% (v/v) TFA 0.1% (v/v) formic acid 
Mobile Phase B: 100% methanol HPLC grade 
 
Isocratic Profile 10% MP A : 90% MP B 
Flow rate 1.00 mL/min 
Run Time 15 minutes 
Column Temperature 35 °C 
Sample Temperature 4 °C 
Injection volume 10 µL 
UV detection wavelength 287 nm, 436 nm and PDA Analysis (210-500 nm)  
Resolution: 1.2 nm 
Diluent 100% HPLC grade methanol 
Solution Filters 0.45 µm Pall GHP filters of code PN-4562 
Test concentration 0.5 mg/mL 
 
On injecting the working standard, four peaks 
were eluted, one of which was more significant than 
the other three (Fig. 3). An injection of the reference 
standard of emodin indicated that the emodin peak 
was expected to elute at approximately 5.9 minutes. 
The peaks were labelled emodin, Unknown 1, 2 and 
3, all of which had excellent USP Tailing and USP 
plate count. The total run time of the system was 15 
minutes which was considerably short. The 
chromatograms at 287 nm and 436 nm were visually 
identical so only chromatograms for the 436 nm 
wavelength are reported in this paper.  
 
The method was run at dual wavelengths, 287 
nm and 436 nm, as they provided two distinctive 
insights into the performance of the analytical 
method. Investigation at 287 nm, albeit having slight 
interferences from the mobile phase additives which 
may reduce the robustness of the method,  offers a 
broader view of the components in the sample since 
most samples absorb at low wavelengths. On the 
other hand, selecting a longer wavelength is more 
selective towards the drug substance and picks up 
less system peaks and degradation products. The 
result of both wavelengths was reported to relate 
both perspectives (Table. 3).  
 
The peaks were all baseline resolved from each 
other with a resolution larger than 3.0 for all the four 
peaks. Nevertheless peak purity testing was 
performed using the Waters Empower software to 
ensure that the peaks were also spectrally pure. A 
max plot for a standard injection analysed using 
system 9 (Tables. 1 and 2) was generated and the 
results are displayed in Table. 4. The results 
indicated the emodin peak was spectrally pure, with 
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purity angle values lower than the purity threshold. 
Thus, the method was specific for emodin as per ICH 
criteria for specificity, namely, “the ability of the 
method to unequivocally assess the analyte in the 
presence of other components that may be expected 
to be present for example, impurities, degradation 
products and matrix components”.  The first two 
peaks in the chromatogram (Fig. 3) were spectrally 
impure (Table. 4) and were hence referred to as 
Unknown 1 and Unknown 2. The second major peak 
in the system, at retention time 10.222 minutes 
(Table 4) was labelled Unknown 3, and with purity 
angle values below the threshold, was also found to 
be spectrally pure. All three unknown peaks were 
most likely impurities or matrix components. The 
next section describes tests that were performed in an 
attempt to identify the unknown peaks. 
 
 
 
Figure 3. Full (A) and expanded (B) chromatograms obtained using chromatographic System 9 at 436 nm; 
Injection peak at 2.361minutes. 
 
Table 3. Chromatographic profile obtained for the optimised HPLC assay method for emodin at 254 nm and    
436 nm. 
At 287nm 
Peak 
number 
Retention time 
(mins) 
Peak name Area 
(µv*sec) 
% Area USP     Plate 
count 
USP tailing 
1 3.096 Unknown 1 101984 2.77 10111 1.160 
2 3.959 Unknown 2 10295 0.28 10752 1.150 
3 5.905 Emodin 17366864 91.36 15941 1.170 
4 10.222 Unknown 3 205965 5.59 18908 1.021 
At 436nm 
Peak 
number 
Retention time 
(mins) 
Peak name Area 
(µv*sec) 
% Area USP     Plate 
count 
USP tailing 
1 3.096 Unknown 1 59603 2.89 10115 1.150 
2 3.959 Unknown 2 6959 0.34 11719 1.203 
3 5.905 Emodin 1863743 90.34 15958 1.168 
4 10.222 Unknown 3 132767 6.44 18937 1.020 
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Table 4. PDA Peak Purity Output obtained using chromatographic System 9 
Peak 
number 
Retention time 
(min) 
Peak name Purity angle Purity threshold Spectral status 
1 3.096 Unknown 1 2.193 0.469 Impure 
2 3.959 Unknown 2 15.182 2.417 Impure 
3 5.905 Emodin 0.217 0.261 Pure 
4 10.222 Unknown 3 0.225 0.402 Pure 
 
Identification of impurities 
Identification of the unknown peaks that had 
eluted in the optimised system was attempted. The 
UV absorption spectra for the four individual peaks 
(Fig. 4) were extracted using the Empower PDA 
software.  
 
On comparing the four absorption spectra, 
several similarities were observed. The peaks and 
troughs of the spectra, as well as the λmax values, 
were similar to each other suggesting that all three 
unknown peaks were anthraquinones, albeit with 
different side groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A common observation made from most systems 
that were investigated is that one of the unknown 
peaks that eluted after emodin was always present in 
the approximate range of 6 to 7.5 % area of the total 
peak area. This was a good indication that the peak 
in these systems represented the same impurity or 
degradation product. Since this component was the 
second most abundant component in the sample it 
was important to attempt to identify its structure. 
